Carlos Nunez, MD
Internal Medicine · Grand Forks, NDNPI 1881181287
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Gilead at 32.7% of the total.
Across 11 payments — averaging $34.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$124
- Lilly USA, LLC$100
- Amgen$66
- Boehringer Ingelheim$24
- Mallinckrodt Hospital Products Inc.$23
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$21
- plus $21 from 1 others
What the payments were for
- Food & beverage$378100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 1 | $124 |
| Lilly USA, LLC | 3 | $100 |
| Amgen | 3 | $66 |
| Boehringer Ingelheim | 1 | $24 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| GSK | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epclusa$124
How this compares
$378 in reported general payments places this provider in the 70th percentile of 159 internal medicine providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 48 | $19,781 |
| Levalbuterol Hcl | 15 | $1,230 |
| Cefpodoxime Proxetil | 35 | $1,175 |
| Budesonide | 18 | $1,022 |
| Atorvastatin Calcium | 57 | $742 |
| Pantoprazole Sodium | 89 | $732 |
| Levothyroxine Sodium | 54 | $596 |
| Carvedilol | 49 | $403 |
| ClopidogrelClopidogrel Bisulfate | 44 | $247 |
| Duloxetine Hcl | 40 | $246 |
| Klor-Con M10Potassium Chloride | 21 | $140 |
| Metoprolol Succinate | 19 | $130 |
| Losartan Potassium | 20 | $126 |
| Omeprazole | 21 | $121 |
| Lisinopril | 31 | $115 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Grand Forks
- Sunil KarthamGrand Forks$507
- Khaled RabadiGrand Forks$425
- Shanta GauthamGrand Forks$374
- Michael LillestolFargo$18K
- Khalin DendyBismarck$10K
- Bruce OlinDickinson$8K
- Gene SchwartzTrenton$6K
- Stephanie CanhamBismarck$4K
- Radu RautaBismarck$3K
- Donald GrenzBismarck$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.